Rapport Therapeutics, Inc. Common Stock (RAPP)

18.83

(-1.26%)

Total Assets Summary of Rapport Therapeutics, Inc. Common Stock

  • Rapport Therapeutics, Inc. Common Stock's latest annual total assets in 2023 was 155.42 Million USD , up 391.8% from previous year.
  • Rapport Therapeutics, Inc. Common Stock's latest quarterly total assets in 2024 Q2 was 346.09 Million USD , up 67.77% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported annual total assets of 31.6 Million USD in 2022, down 0.0% from previous year.
  • Rapport Therapeutics, Inc. Common Stock reported quarterly total assets of 206.28 Million USD for 2024 Q1, up 32.73% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported quarterly total assets of 155.42 Million USD for 2023 FY, up 391.8% from previous quarter.

Annual Total Assets Chart of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Historical Annual Total Assets of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Year Total Assets Total Assets Growth
2023 155.42 Million USD 391.8%
2022 31.6 Million USD 0.0%

Peer Total Assets Comparison of Rapport Therapeutics, Inc. Common Stock

Name Total Assets Total Assets Difference